$CHWY

Singh Sumit sold $143K of CHWY (indirect holdings)

Singh Sumit (Chief Executive Officer) sold 6,233 indirectly-held shares of Chewy, Inc. (CHWY) at $23.01 ($0.14M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Singh Sumit
Published Aug 4, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHWY
Neutral
medium confidence
Mentioned
$CHWY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHWYNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (shares, price, total value) by the CEO, executed under a 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing makes it unlikely to drive a durable repricing without additional company-specific catalysts.

03

What to watch

The article does not provide context on total planned sales, prior insider activity cadence, or whether indirect holdings are tied to specific vehicles, limiting inference.

Relevance 3/10Novelty 3/10Timing: Filed 2026-08-04, covering a sale executed 2026-08-03.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Chewy, Inc. (CHWY).

Company-level read

Ticker impact

$CHWYNeutralMedium confidence
Context

Chewy CEO Sumit Singh filed a Form 4 showing an open-market sale of 6,233 shares at $23.01 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited and sentiment-driven.

Evidence & confidence

The filing discloses transaction size, price, and that it is under a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

Minimal. Insider sales under 10b5-1 do not typically change sector fundamentals for retail/consumer e-commerce.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Chewy, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Singh Sumit

    Chewy CEO and reporting person who sold shares.

  • 10b5-1 plan

    Pre-arranged plan that reduces discretionary-signal interpretation.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

$CHWYMed

Chewy Puts a $50 Million Price Tag on AI Productivity

Chewy expects AI to reduce costs by $50M in fiscal 2027, up from low tens of millions this year. CEO Sumit Singh attributes savings to AI tools in customer service, pharmacy, and veterinary care. The company's AI assistant, Cai, handles 30% of chats without human agents. AI tools also improve internal operations and pharmacy processes. Chewy built the AI infrastructure in-house, giving it a competitive advantage. The savings will offset wage inflation and fund growth initiatives.

$CHWYMed

Chewy rises as Goldman Sachs maintains Buy rating on stock

Chewy Inc. shares rose 6.78% to $19.06 after Goldman Sachs maintained a Buy rating but lowered its price target to $34 from $46. The company reported Q1 earnings beat but reduced its fiscal 2026 sales outlook, prompting multiple analysts to cut price targets. Chewy's stock is down 56.34% over the past year and trades near its 52-week low.

$CHWYMedAI 8/10

CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom?

Chewy (CHWY) shares rose 6% to $21.75, despite a 34% YTD decline. The company reported 7.3% sales growth, raised full-year revenue guidance, and maintained gross margin at 30.4%. Cash decreased to $611M due to acquisitions and share buybacks. The broader pet-care sector has underperformed, with the PAWZ ETF down 10% YTD. Investors await Q3 2026 results to assess margin expansion and potential bottom.

$CHWYMedAI 8/10

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy (CHWY) reported Q2 2026 net sales of $3.33B, up 7.3%, and adjusted EPS of $0.36. The company raised its full-year outlook, but analysts downgraded the stock and cut price targets. CHWY stock fell 10% intraday after the results. Active customers rose 3.8% to 21.7M. Organic revenue growth slowed to 5.7%, and adjusted EBITDA margin benefited from non-recurring items. Analysts debate whether the slowdown is cyclical or structural.

$CHWYMedAI 8/10

CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook

Chewy Inc. (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, meeting estimates. Adjusted EPS rose to $0.36, missing estimates by 1%. Gross margin remained unchanged at 30.4%, while adjusted EBITDA increased 23.7% to $226.7M. Chewy raised its FY26 revenue outlook but narrowed EBITDA margin guidance. CHWY stock fell 7% in morning trade, hitting a one-month low.